7 employees
Onconic Therapeutics specialises in the research and development of cancer treatments.
2020
$21M
from 3 investors over 3 rounds
Onconic Therapeutics raised $21M on December 9, 2022
Investors: Premier Partners, Korea Development Bank and AJU IB INVESTMENT